← Back to Search

Neuromuscular Blocker

Neuromuscular blockade for Extracorporeal Membrane Oxygenation (PNEUMA Trial)

N/A
Waitlist Available
Led By Ewan Goligher, MD, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed maintenance 24 hours phase
Awards & highlights

PNEUMA Trial Summary

This trial is testing a new way to help people with a severe lung disease who are using a machine to help them breathe.

Eligible Conditions
  • Extracorporeal Membrane Oxygenation
  • Neuromuscular Blockade
  • Respiratory Insufficiency

PNEUMA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed maintenance 24 hours phase
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed maintenance 24 hours phase for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of patients achieving and maintaining targeted esophageal pressure swings
Secondary outcome measures
Rates of serious adverse events

PNEUMA Trial Design

1Treatment groups
Experimental Treatment
Group I: Partial NMBExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,475 Previous Clinical Trials
485,086 Total Patients Enrolled
Ewan Goligher, MD, PhDPrincipal InvestigatorUniversity Health Network, Toronto
7 Previous Clinical Trials
6,598 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025